Back to calendar
Regeneron Pharmaceuticals, Inc. (REGN) Earnings
REGN reports earnings on Thursday, October 29, 2026
earnings report
October 29, 2026 · Before Market Open
Q3 2026
Est. EPS: $16.00
Actual EPS: $14.29
EPS surprise: 40.69%
Company overview
Market Cap$84.6B
PriceUSD 821.75
P/E20.31
EPS (TTM)40.46
52-week high847.00
52-week low541.00
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees15,410